top of page

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

ULY CLINIC

18 Februari 2026, 09:19:02

Tropical Pyomyositis
Tropical Pyomyositis
Tropical Pyomyositis
Tropical Pyomyositis

Tropical Pyomyositis

18 Februari 2026, 09:19:02

Tropical pyomyositis is a primary bacterial infection of skeletal muscle characterized by localized abscess formation, muscle necrosis, and systemic inflammatory response. It predominantly affects large muscle groups and occurs most frequently in tropical and subtropical climates.

Unlike secondary muscle infection, it arises without adjacent skin infection, osteomyelitis, or penetrating trauma in many cases.


Epidemiology

  • Common in tropical regions (Africa, Asia, Latin America)

  • Affects children and young adults most frequently

  • Male predominance

  • Increasingly recognized worldwide due to migration and immunosuppression

Incidence increases in:

  • Malnutrition

  • HIV infection

  • Diabetes mellitus

  • Sickle cell disease

  • Immunosuppressive therapy


Etiology

The most common organism isStaphylococcus aureus (≈ 70–95%)

Other causes:

  • Streptococcus species

  • Gram-negative bacilli

  • Anaerobes (rare)

  • Mixed infections in immunocompromised patients

Early lesions may be sterile due to:

  • Hematogenous seeding

  • Delayed abscess formation


Pathophysiology

  1. Transient bacteremia

  2. Seeding of skeletal muscle

  3. Muscle inflammation

  4. Suppuration and necrosis

  5. Abscess formation

Muscle normally resists infection, but risk increases with:

  • Trauma or vigorous exercise

  • Malnutrition

  • Viral infections

  • Parasitemia (e.g., malaria)

  • Immunodeficiency


Commonly Affected Muscles

  • Quadriceps (most common)

  • Gluteal muscles

  • Iliopsoas

  • Calf muscles

  • Shoulder girdle

Usually involves large muscles of lower limbs


Clinical Stages


Stage 1 – Invasive Stage (1–2 weeks)

  • Low-grade fever

  • Muscle ache

  • Firm swelling

  • Minimal tenderness

  • No fluctuation

Often misdiagnosed as muscle strain.


Stage 2 – Suppurative Stage (Most common presentation)

  • High fever

  • Severe pain

  • Fluctuant swelling

  • Local warmth

  • Restricted movement

Abscess forms.


Stage 3 – Late Stage (Septic stage)

  • Sepsis

  • Tachycardia

  • Hypotension

  • Septic shock

  • Multiple abscesses

  • Organ failure

Life-threatening.


Signs and Symptoms

  • Fever

  • Painful muscle swelling

  • Induration

  • Fluctuation (abscess stage)

  • Restricted limb movement

  • Limping or inability to walk

  • Malaise

  • Night sweats (sometimes)


Diagnostic Criteria

Diagnosis is clinical plus supportive tests:

Key clinical feature

  • Fever + painful indurated or fluctuant large muscle


Differential Diagnosis

  • Cellulitis

  • Deep vein thrombosis

  • Septic arthritis

  • Osteomyelitis

  • Muscle hematoma

  • Soft tissue tumor

  • Necrotizing fasciitis


Investigations


Laboratory

  • FBC → leukocytosis

  • ESR ↑

  • CRP ↑

  • Blood culture (may be positive in late disease)

Imaging


Ultrasound

  • Detects abscess

  • Guides drainage


MRI (best test)

  • Detects early muscle inflammation

  • Shows extent of necrosis


CT scan

  • Alternative when MRI unavailable


Pus Culture

Confirms organism (usually S. aureus)


Treatment

Early treatment prevents sepsis and disability.


Pharmacological Treatment


Adults

Flucloxacillin 250 mg + Amoxicillin 250 mg PO every 6 hours for 14 days

OR

Erythromycin 500 mg PO every 6 hours for 14 days


Children

Cloxacillin 25 mg/kg IV every 6 hours for 14 days

OR

Erythromycin 10 mg/kg every 6 hours for 14 days


Severe Disease (Recommended clinical practice)

  • Start IV anti-staphylococcal therapy

  • Switch to oral after improvement

  • Total duration: 3–4 weeks


Non-Pharmacological Management


Abscess Stage

  • Surgical incision and drainage (essential)

  • Repeated drainage if needed

  • Immobilization of affected limb

  • Analgesia and hydration


Septic Stage

  • ICU care

  • Fluid resuscitation

  • Sepsis protocol


Complications

  • Septicemia

  • Multiple muscle abscesses

  • Osteomyelitis

  • Septic arthritis

  • Compartment syndrome

  • Death (late stage)


Prognosis

  • Excellent if treated early

  • Good after drainage + antibiotics

  • Poor if septic shock develops

Mortality mainly in late untreated cases.


Prevention

  • Early treatment of skin infections

  • Prompt management of trauma

  • Good nutrition

  • Malaria prevention in endemic areas

  • Glycemic control in diabetics

  • Early medical evaluation of persistent muscle pain


Patient Education

Patients should be advised to seek care if they develop:

  • Fever with localized muscle swelling

  • Severe muscle pain after minor trauma

  • Difficulty walking

Avoid self-treatment with massage — may worsen abscess spread.


References

  1. Crum NF. Bacterial pyomyositis in the United States. Am J Med. 2004;117(6):420-428.

  2. Chauhan S, Jain S, Varma S, Chauhan SS. Tropical pyomyositis (myositis tropicans). J Glob Infect Dis. 2014;6(2):75-80.

  3. Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO, Kaplan SL. Infectious myositis in children. Pediatr Infect Dis J. 2006;25(5):421-424.

  4. Hall RL, Callaghan JJ, Moloney E, Martinez S, Harrelson JM. Pyomyositis in a temperate climate. J Bone Joint Surg Am. 1990;72(8):1240-1244.

  5. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for skin and soft tissue infections. Clin Infect Dis. 2014;59(2):147-159.

  6. Ministry of Health Tanzania. Standard Treatment Guidelines & National Essential Medicines List. 2023 edition. Dodoma: MoHCDGEC; 2023.


Imeandikwa:

6 Novemba 2020, 07:54:56

bottom of page